Christophe Ferrand

4.3k total citations
103 papers, 2.8k citations indexed

About

Christophe Ferrand is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Christophe Ferrand has authored 103 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 46 papers in Oncology and 30 papers in Genetics. Recurrent topics in Christophe Ferrand's work include CAR-T cell therapy research (30 papers), Immune Cell Function and Interaction (29 papers) and Virus-based gene therapy research (24 papers). Christophe Ferrand is often cited by papers focused on CAR-T cell therapy research (30 papers), Immune Cell Function and Interaction (29 papers) and Virus-based gene therapy research (24 papers). Christophe Ferrand collaborates with scholars based in France, United States and Germany. Christophe Ferrand's co-authors include Pierre Tiberghien, Philippe Saas, Marina Deschamps, Anne Duperrier, Jamal Bamoulid, Delphine Sauce, Éric Robinet, Jean‐Marc Chalopin, Éric Deconinck and Jean-Michel Rebibou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Christophe Ferrand

101 papers receiving 2.7k citations

Peers

Christophe Ferrand
John Prehn United States
Eva M. Weissinger Germany
Shirley Zhu United States
Shiguang Qian United States
Elmar Jaeckel Germany
David Senitzer United States
Antonio López‐Vázquez Spain
Ronjon Chakraverty United Kingdom
Paul A. Blair United Kingdom
Sylvie Ferrari‐Lacraz Switzerland
John Prehn United States
Christophe Ferrand
Citations per year, relative to Christophe Ferrand Christophe Ferrand (= 1×) peers John Prehn

Countries citing papers authored by Christophe Ferrand

Since Specialization
Citations

This map shows the geographic impact of Christophe Ferrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Ferrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Ferrand more than expected).

Fields of papers citing papers by Christophe Ferrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Ferrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Ferrand. The network helps show where Christophe Ferrand may publish in the future.

Co-authorship network of co-authors of Christophe Ferrand

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Ferrand. A scholar is included among the top collaborators of Christophe Ferrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Ferrand. Christophe Ferrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bellaye, Pierre‐Simon, et al.. (2022). IL-1RAP, a Key Therapeutic Target in Cancer. International Journal of Molecular Sciences. 23(23). 14918–14918. 13 indexed citations
3.
Camus, Vincent, Arnaud François, Christophe Ferrand, et al.. (2021). Kidney Transplant T Cell–Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case Report. American Journal of Kidney Diseases. 79(5). 760–764. 17 indexed citations
4.
Wilmes, Stephan, Walid Warda, Elizabeth Pöhler, et al.. (2020). Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. Science Signaling. 13(649). 60 indexed citations
5.
Renosi, Florian, et al.. (2020). Post-Essential Thrombocythemia Myelofibrosis and Multiple Isodicentric Y Chromosomes: A Unique Case among a Rare Association. Cytogenetic and Genome Research. 160(1). 18–21. 1 indexed citations
6.
Warda, Walid, Fabrice Larosa, Éric Deconinck, et al.. (2018). CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells. Cancer Research. 79(3). 663–675. 68 indexed citations
7.
Deschamps, Marina, Christophe Ferrand, Charline Vauchy, et al.. (2018). Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy. Human Gene Therapy. 29(10). 1202–1212. 9 indexed citations
8.
Larosa, Fabrice, Éric Deconinck, Pierre Tiberghien, et al.. (2016). Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts. Gene Therapy. 23(8-9). 664–672. 7 indexed citations
9.
Gallot, Géraldine, Soraya Saïagh, Béatrice Clemenceau, et al.. (2014). T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells. Journal of Immunotherapy. 37(3). 170–179. 42 indexed citations
10.
Masson, Emeline, Chrystelle Vidal, Marina Deschamps, et al.. (2013). Incidence and risk factors of anti-HLA immunization after pregnancy. Human Immunology. 74(8). 946–951. 52 indexed citations
11.
Daguindau, Étienne, Christophe Ferrand, Jamal Bamoulid, et al.. (2013). A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinib. Leukemia Research Reports. 2(1). 29–31. 17 indexed citations
12.
Bedel, Romain, Antoine Thiery-Vuillemin, Camille Grandclément, et al.. (2011). Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells. Cancer Research. 71(5). 1615–1626. 94 indexed citations
13.
Eljaafari, Assia, Lionel Badet, Jean Kanitakis, et al.. (2006). Isolation of Regulatory T Cells in the Skin of a Human Hand-Allograft, Up to Six Years Posttransplantation. Transplantation. 82(12). 1764–1768. 47 indexed citations
14.
Bonyhadi, Mark, Mark W. Frohlich, Angela L. Rasmussen, et al.. (2005). In Vitro Engagement of CD3 and CD28 Corrects T Cell Defects in Chronic Lymphocytic Leukemia. The Journal of Immunology. 174(4). 2366–2375. 31 indexed citations
15.
Tiberghien, Pierre, et al.. (2003). La réactivité allogénique dirigée contre le receveur lors d‘une greffe hématopoïétique. Bulletin du Cancer. 90(8). 706–710. 1 indexed citations
16.
Sauce, Delphine, Anne Duperrier, Manoel de Carvalho, et al.. (2002). Influence of Ex Vivo Expansion and Retrovirus-Mediated Gene Transfer on Primary T Lymphocyte Phenotype and Functions. Journal of Hematotherapy & Stem Cell Research. 11(6). 929–940. 26 indexed citations
17.
Carvalho, Manoel de, Philippe Saas, Stéphanie Fresnay, et al.. (2001). Exposure to exogenous DNA can modify the sensitivity of the Fas apoptotic pathway. The Journal of Gene Medicine. 4(1). 14–24. 7 indexed citations
18.
Maddens, Stéphane, Pierre Tiberghien, Emmanuel Contassot, et al.. (2000). Development of a Competitive PCR Method for In Vitro and In Vivo Quantification of Herpes Simplex Virus Thymidine Kinase and Neomycin Resistance-Expressing Cells Used in a Clinical Trial. Journal of Hematotherapy & Stem Cell Research. 9(2). 225–236. 13 indexed citations
19.
Robinet, Éric, Christophe Ferrand, Phillip B. Maples, et al.. (1998). A Closed Culture System for the Ex Vivo Transduction and Expansion of Human T Lymphocytes. Journal of Hematotherapy. 7(3). 205–215. 30 indexed citations
20.
Contassot, Emmanuel, Christophe Ferrand, Craig W. Reynolds, et al.. (1998). Retrovirus-Mediated Transfer of the Herpes Simplex Type I Thymidine Kinase Gene in Alloreactive T Lymphocytes. Human Gene Therapy. 9(1). 73–80. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Prehn Breakdown of academic impact, for papers by Eva M. Weissinger Breakdown of academic impact, for papers by Shirley Zhu Breakdown of academic impact, for papers by Shiguang Qian Breakdown of academic impact, for papers by Elmar Jaeckel Breakdown of academic impact, for papers by David Senitzer Breakdown of academic impact, for papers by Antonio López‐Vázquez Breakdown of academic impact, for papers by Ronjon Chakraverty Breakdown of academic impact, for papers by Paul A. Blair Breakdown of academic impact, for papers by Sylvie Ferrari‐Lacraz
Rankless by CCL
2026